Most Popular - Weight-loss drug makers popped Wednesday morning after mega-insurer Aetna (NYSE:AET) issued a bulletin on weight reduction medications and procedures. Qysmia, from Vivus (NASDAQ:VVUS), and Arena’s … Continue Reading
Read nowLong Ideas - BGI-Shenzhen has extended the acceptance deadline for its $3.15 per share tender offer for Complete Genomics (NASDAQ:GNOM), but the elephant in the room – or … Continue Reading
Read nowQuick Picks - Medtronic Inc. (NYSE:MDT) posted in-line adjusted earnings and a slight revenue miss in the second quarter of its fiscal year 2013, but expects overall sales growth for … Continue Reading
Read nowLong Ideas - Last week, the FDA accepted Navidea Biopharmaceuticals’ (NASDAQ:NAVB) resubmitted New Drug Application for Lymphoseek and set an April 30 PDUFA goal. Navidea’s submission was met … Continue Reading
Read nowQuick Picks - Less than a month after rejecting a previous takeover bid, Taro Pharmaceutical Industries (NYSE:TARO) in August accepted long-time pursuer Sun Pharmaceutical Industries’ $39.50/share purchase price, … Continue Reading
Read nowQuick Picks - After declines in the first half of the week, shares of Threshold Pharmaceuticals (NASDAQ:THLD) rebounded on Thursday morning following an update on the company’s ongoing … Continue Reading
Read nowLong Ideas - Puma Biotechnology (NYSE:PBYI) made waves last month when it uplisted to the NYSE and initiated a substantial capital raise, increasing cash and equivalents to approximately … Continue Reading
Read now